Cargando…
Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells
Chemoresistance to anticancer drugs is a major obstacle in the efforts to develop a successful treatment strategy for esophageal squamous carcinoma (ESCC). Thus, the exploration of new drugs and treatment strategies for combating resistance are of utmost importance. In this study, we investigated th...
Autores principales: | Wang, Cong, Guo, Liubin, Wang, Saiqi, Wang, Junwei, Li, Yongmei, Dou, Yinhui, Wang, Ran, Shi, Hongge, Ke, Yu, Liu, Hongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360389/ https://www.ncbi.nlm.nih.gov/pubmed/28204832 http://dx.doi.org/10.3892/ijmm.2017.2867 |
Ejemplares similares
-
The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells
por: Wang, Cong, et al.
Publicado: (2015) -
Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs
por: Xie, Li, et al.
Publicado: (2009) -
Effects of cyclin E gene silencing on the proliferation of esophageal cancer cell lines, EC9706, Eca109 and KYSE30
por: Wang, Na, et al.
Publicado: (2018) -
UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo
por: Gao, Xiaojia, et al.
Publicado: (2016) -
Effect of Food Additive Citric Acid on The Growth of
Human Esophageal Carcinoma Cell Line EC109
por: Chen, Xiaoguang, et al.
Publicado: (2017)